BOC Sciences provides a wide range of research chemicals and biochemicals including inhibitors, building blocks, GMP Products, impurities and metabolites, APIs for Veterinary, Natural Compounds, ADCs, Stem Cell Molecule and chiral compounds.
| Product | Description | |
|---|---|---|
| G5-7 | G5-7 is an orally active and allosteric JAK2 inhibitor. G5-7 induces cell cycle arrest, apoptosis and possesses antiangiogenic effect. G5-7 has the potential for glioma study. Synonyms: tert-Butyl 3,5-bis(2-fluorobenzylidene)-4-oxopiperidine-1-carboxylate; 939681-36-4; starbld0009706. Grade: 99%. CAS No. 939681-36-4. Molecular formula: C22H19F2NO3. Mole weight: 383.39. |  |
| G 573 | G 573 is used as an EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor and an antineoplastic agent. Synonyms: Furo[3,2-c]pyridine-2-carboxamide, 7-fluoro-3-[(2-fluoro-4-iodophenyl)amino]-N-[(2S)-2-hydroxypropoxy]-; 7-Fluoro-3-[(2-fluoro-4-iodophenyl)amino]-N-[(2S)-2-hydroxypropoxy]furo[3,2-c]pyridine-2-carboxamide; 7-Fluoro-3-[(2-fluoro-4-iodophenyl)amino]furo[3,2-c]pyridine-2-carboxylic acid N-[((S)-2-hydroxypropyl)oxy]amide; G-573; G573. Grade: 95%. CAS No. 1009333-44-1. Molecular formula: C17H14F2IN3O4. Mole weight: 489.21. | |
| G-573 | G-573 is an allosteric inhibitor of MEK that is both potent and selective. The IC(50) value for pERK inhibition in HCT116 tumours by G-573 was estimated to be 0.406? μM. The IC(50) values for tumour growth inhibition in HCT116 and H2122 were estimated to be 3.43 and 2.56?μM, respectively. ED(50) estimates in HCT116 and H2122 mouse xenograft models were estimated to be ~4.6 and 1.9?mg/kg/day, respectively. Synonyms: G 573; G573; 2-(3-chlorophenyl)benzimidazole; OTAVA-BB; 1H-Benzimidazole, 2-(3-chlorophenyl)-; Benzimidazole, 2-(m-chlorophenyl)-. 2-(3-Chlorophenyl)-1H-1,3-benzodiazole; 2-(3'-Chlorophenyl)benzimidazole; 2-(m-Chlorophenyl)benzimidazole. Grade: ≥95%. CAS No. 22868-35-5. Molecular formula: C13H9ClN2. Mole weight: 228.68. | |
| G6PDi-1 | G6PDi-1 is a small molecule inhibitor of glucose-6-phosphate dehydrogenase (G6PD). G6PDi-1 depletes NADPH and decreases inflammatory cytokine production. Synonyms: G6PDi-1; 2457232-14-1; 4-((5-Oxo-6,7,8,9-tetrahydro-5H-cyclohepta[d]pyrimidin-2-yl)amino)thiophene-2-carbonitrile4-[(5-oxo-6,7,8,9-tetrahydrocyclohepta[d]pyrimidin-2-yl)amino]thiophene-2-carbonitrile; EX-A3990. CAS No. 2457232-14-1. Molecular formula: C14H12N4OS. Mole weight: 284.34. | |
| G-749 | G-749 potently inhibits autophosphorylation of FLT3 with IC50 of ≤8 nM. In leukemia cells, G-749 shows antiproliferative activity by inducing apoptosis. Synonyms: G749; G-749; G 749. Grade: >98%. CAS No. 1457983-28-6. Molecular formula: C25H25BrN6O2. Mole weight: 521.41. | |
| GA1-Ganglioside | GA1-Ganglioside is a potent compound used to study Gangliosidosis Type 1, a rare and progressive genetic disorder. Derived from natural sources, this product can replenish the deficient GA1-ganglioside enzyme. Synonyms: Ganglio-N-tetraosylceramide; Ceramide tetrahexoside; GgOse4Cer; asialo-GM1; 1-O-[O-β-D-Galactopyranosyl-(1→3)-O-2-(acetylamino)-2-deoxy-β-D-galactopyranosyl-(1→4)-O-β-D-galactopyranosyl-(1→4)-β-D-glucopyranosyl]-ceramide; Asialo ganglioside GM1a; Asialo GM1; Asialo GM1 ganglioside; Asialoganglioside GM1; Asialoganglioside GT1b; Ganglioside GA1; Gangliotetraosylceramide; Gg4Cer. CAS No. 71012-19-6. Molecular formula: C62H114N2O23. Mole weight: 1255.6. | |
| GA2-Ganglioside | GA2-Ganglioside, a glycolipid situated on the cell surface, performs a crucial action by boosting communication between neighboring nerve cells in the nervous system. Its medicinal potency in treating diverse neurological illnesses, including Parkinson's and Alzheimer's, has been researched extensively. Furthermore, it seems GA2-Ganglioside promotes the functionality and longevity of dopaminergic neurons, making it a highly sought-after therapy for Parkinson's. Synonyms: Asialoganglioside-GM2; Gangliotriosyl ceramide; GgOse3Cer; b-GalNAc-(1→4)-b-Gal-(1→4)-b-Glc-(1→1)-Cer; Ceramide, 1-O-[O-2-(acetylamino)-2-deoxy-β-D-galactopyranosyl-(1→4)-O-β-D-galactopyranosyl-(1→4)-β-D-glucopyranosyl]-; 1-O-[O-2-(Acetylamino)-2-deoxy-β-D-galactopyranosyl-(1→4)-O-β-D-galactopyranosyl-(1→4)-β-D-glucopyranosyl]-ceramide; Asialo Gm2; Asialoganglioside GM2; Cg3Cer; Ganglio-N-triaosylceramide; Ganglioside A2; Ganglioside GA2; Ganglioside Gg3; Gangliotriaosylceramide; Gangliotriosylceramide; Gg3Cer; Glycolipid GA2; Glycosphingolipid GA2; Tay-Sachs globoside. CAS No. 35960-33-9. Molecular formula: C56H104N2O18. Mole weight: 1093.43. | |
| GABAA receptor agent 2 TFA | GABAA receptor agent 2 TFA is a potent and high-affinity antagonist of GABAA receptor with an IC50 of 24 nM for human α1β2γ2 GABAA-expressing tsA201 cells and a Ki of 28 nM for rat GABAA receptors. It has no inhibitory activity against four human GABA transporters (hGAT-1, hBGT-1, hGAT-2, and hGAT-3). Synonyms: PHP 501 trifluoroacetate; 4-(5-[1,1'-Biphenyl]-3-yl-1-hydroxy-1H-pyrazol-4-yl)piperidine trifluoroacetate; 5-([1,1'-Biphenyl]-3-yl)-4-(piperidin-4-yl)-1H-pyrazol-1-ol 2,2,2-trifluoroacetate; 5-(3-Biphenylyl)-4-(4-piperidinyl)-1H-pyrazol-1-ol trifluoroacetate (1:1). Grade: ≥95%. CAS No. 1781880-44-1. Molecular formula: C22H22F3N3O3. Mole weight: 433.42. | |
| GABAB receptor antagonist 1 | GABAB receptor antagonist 1, a selective and negative allosteric modulator of GABAB (γ-aminobutyric acid) receptors, reduces GABA-induced IP3 (inositol triphosphate) production with an IC50 of 37.9 μM. Synonyms: 4-[4-Hydroxy-3,5-bis(2-methyl-2-propanyl)phenyl]-2-oxo-3-butenoic acid; 3-Butenoic acid, 4-[3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl]-2-oxo-. Grade: ≥95%. CAS No. 797-17-1. Molecular formula: C18H24O4. Mole weight: 304.38. | |
| Gabalactum Lactose Impurity 1 | An impurity of Gabapentin, which is a γ-aminobutyric acid (GABA) analog used primarily to manage neuropathic pain, partial seizures, and conditions like postherpetic neuralgia. Gabapentin binds to the α2δ subunit of voltage-gated calcium channels in the central nervous system, reducing calcium influx and inhibiting the release of excitatory neurotransmitters. Synonyms: 2-(4-O-β-D-Galactopyranosyl-D-glucopyranosyl)-2-azaspiro[4.5]decan-3-one; Gabapentin lactose Adduct. Grade: ≥95%. CAS No. 1989748-31-3. Molecular formula: C21H35NO11. Mole weight: 477.50. | |
| Gabalactum Lactose Impurity 2 | An impurity of Gabapentin, which is a γ-aminobutyric acid (GABA) analog used primarily to manage neuropathic pain, partial seizures, and conditions like postherpetic neuralgia. Gabapentin binds to the α2δ subunit of voltage-gated calcium channels in the central nervous system, reducing calcium influx and inhibiting the release of excitatory neurotransmitters. Synonyms: Gabapentin lactose Adduct; 2-((2,3-Dihydroxy-5-(hydroxymethyl)-4-(((2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)tetrahydrofuran-2-yl)methyl)-2-azaspiro[4.5]decan-3-one. Grade: ≥95%. CAS No. 1990449-64-3. Molecular formula: C21H35NO11. Mole weight: 477.51. | |
| Gabapentin Enacarbil-d7 | Gabapentin Enacarbil-d7 is a labelled Gabapentin Enacarbil, which is a long-acting prodrug of Gabapentin used in the treatment of restless legs syndrome (RLS) and postherpetic neuralgia (PHN). Grade: > 95%. Molecular formula: C16H20NO6D7. Mole weight: 336.44. | |
| Gabapentin EP Impurity G | An impurity of Gabapentin, which is a γ-aminobutyric acid (GABA) analog used primarily to manage neuropathic pain, partial seizures, and conditions like postherpetic neuralgia. Gabapentin binds to the α2δ subunit of voltage-gated calcium channels in the central nervous system, reducing calcium influx and inhibiting the release of excitatory neurotransmitters. Synonyms: (1-(2-aminoethyl)cyclohexyl)acetic acid. Grade: > 95%. CAS No. 1500558-49-5. Molecular formula: C10H19NO2. Mole weight: 185.27. | |
| Gabapentin hydrochloride | Gabapentin HCl is a GABA analogue.Originally it was developed to treat epilepsy, and is currently used to relieve neuropathic pain and restless leg syndrome. Synonyms: Gabapentin Hydrochloride; Gabapentin HCl; 60142-95-2; Gabapentin (hydrochloride); Gabarone; 1-(Aminomethyl)cyclohexaneacetic acid HCl; Cyclohexaneacetic acid, 1-(aminomethyl)-, hydrochloride; N0PY5N5AFW; 2-(1-(aminomethyl)cyclohexyl)acetic acid hydrochloride; 60142-95-2 (HCl); 2-[1-(aminomethyl)cyclohexyl]acetic acid hydrochloride; UNII-N0PY5N5AFW; 1-(Aminomethyl)cyclohexaneacetic acid hydrochloride; Neurontin HCl. Grade: >98%. CAS No. 60142-95-2. Molecular formula: C9H17NO2.HCl. Mole weight: 207.7. | |
| Gabapentin Impurity 1 | Gabapentin Impurity 1 is a piperidinedione derivative. Synonyms: 2,4-Dioxo-3-Azaspiro[5.5]Undecane-1,5-Dicarbonitrile; 8,10-Diketo-9-Azaspiro[5.5]Undecane-7,11-Dicarbonitrile; Nsc169442; α,α'-Dicyano-1,1-cyclohexanediacetamide; NSC 408757. Grade: > 95%. CAS No. 4355-15-1. Molecular formula: C12H13N3O2. Mole weight: 231.26. | |
| Gabapentin Impurity 2 | Gabapentin Impurity 2 is a pervasive compound employed in the realm of biomedicine. Its broad-spectrum utility manifests in navigating diverse neurological predicaments, embracing the likes of epilepsy and neuropathic pain. An augmenting agent, Gabapentin Impurity 2, intensifies the therapeutic prowess of its well-renowned counterpart, Gabapentin, extensively harnessed as an antiepileptic remedy. Synonyms: 3,3-Pentamethyleneglutaric Acid; Cyclohexane-1,1'-diacetic acid; 1,1-Cyclohexanediacetic acid; Cyclohexanediacetic acid; 1,1-Bis(carboxymethyl)cyclohexane; NSC 169443; NSC 39839. Grade: > 95%. CAS No. 4355-11-7. Molecular formula: C10H16O4. Mole weight: 200.24. | |
| Gabapentin Impurity (2-(3-Oxobutyl)-2-Azaspiro-(4,5)-decan-3-one) | Gabapentin Impurity (2-(3-Oxobutyl)-2-Azaspiro-(4,5)-decan-3-one). Grade: > 95%. Molecular formula: C13H21NO2. Mole weight: 223.32. | |
| Gabapentin Impurity 3 | Gabapentin Impurity 3 is a chemical with potential use for biochemical research, especially in the field of neurobiology. It is Gabapentin intermediate. Synonyms: 3,3-Pentamethyleneglutarimide; 1,1-Cyclohexane diacetimide; 3,3-Pentamethylene Glutarimide; 2,4-Dioxo-3-azaspiro[5.5]undecane; 1,1-Cyclohexanediacetimide; 3-Azaspiro[5.5]undecane-2,4-dione; NSC 400093. Grade: > 95%. CAS No. 1130-32-1. Molecular formula: C10H15NO2. Mole weight: 181.24. | |
| Gabapentin Related Compound E | Gabapentin Related Compound E is a Gabapentin analogue. Synonyms: 1-Carboxycyclohexaneacetic acid; NSC 90823; Gabapentin USP RC E; 1-(CarboxyMethyl)cyclohexane-1-carboxylic acid. Grade: > 95%. CAS No. 67950-95-2. Molecular formula: C9H14O4. Mole weight: 186.21. | |
| Gabapentin Related Material B | Gabapentin Related Material B is a Gabapentin analogue for treatment of neurological disorders. Synonyms: (1-cyanocyclohexyl)acetic acid; 2-(1-Cyanocyclohexyl)acetic acid; Gabapentin USP RC B; 1-Cyanocyclohexaneacetic Acid; USP Gabapentin Related Compound B. Grade: > 95%. CAS No. 133481-09-1. Molecular formula: C9H13NO2. Mole weight: 167.21. | |
| Gabapentin Related Material D | Gabapentin Related Material D is a Gabapentin analogue. Synonyms: 1-[(3-Oxo-2-azaspiro[4.5]dec-2-yl)methyl]cyclohexaneacetic acid; [1-(3-Oxo-2-aza-spiro[4,5]dec-2-ylmethyl)cyclohexyl]acetic Acid; USP Gabapentin Related Compound D; Gabapentin USP RC D. Grade: > 95%. CAS No. 1076198-17-8. Molecular formula: C18H29NO3. Mole weight: 307.44. | |
| Gabexate | Gabexate mesylate is a serine protease inhibitor used therapeutically in the treatment of pancreatitis, disseminated intravascular coagulation, and as a regional anticoagulant for haemodialysis. Uses: Serine protease inhibitor. Synonyms: GABEXATE; GabexateMesylateBase; [N'-[5-(4-ethoxycarbonylphenoxy)carbonylpentyl]carbamimidoyl]azanium methanesulfonate; 4-[(6-Guanidinohexanoyl)oxy]benzoic acid ethyl ester; 4-[[6-[[Amino(imino)methyl]amino]-1-oxohexyl]oxy]benzoic acid ethyl ester. Grade: ≥98%. CAS No. 39492-01-8. Molecular formula: C16H23N3O4. Mole weight: 321.375. | |
| Gabexate mesylate | Gabexate is a serine protease inhibitor that inhibits trypsin (IC50= 9.4μM), plasmin (IC50= 30μM), plasma kallikrein (IC50= 41μM) and thrombin (IC50= 110μM). It is used therapeutically (as gabexate mesilate) in the treatment of pancreatitis, disseminated intravascular coagulation, and as a regional anticoagulant for haemodialysis. Synonyms: 4-[[6-[(Aminoiminomethyl)amino]-1-oxohexyl]oxy]-benzoic acid ethyl ester mesylate; Gabexate; Gabexate mesylate; gabexate mesilate. Arodate; Megacart; Megacert; Mesyl Gabexate; Arodate. CAS No. 56974-61-9. Molecular formula: C17H27N3O7S. Mole weight: 417.48. | |
| GABOB (beta-hydroxy-GABA) | GABOB, also known as γ-Amino-β-hydroxybutyric acid, β-hydroxy-γ-aminobutyric acid, β-hydroxy-GABA, is an anticonvulsant. It is also an endogenous active metabolite and analogue of the neurotransmitter γ-aminobutyric acid (GABA), and for this reason, may function as a neurotransmitter itself. Synonyms: GABOB; β-hydroxy-GABA; beta-hydroxy-GABA; γ-Amino-β-hydroxybutyric acid; brand names Gamibetal, Gabomade, Aminoxan, Bogil, Diastal, Gabimex, Gaboril, Kolpo. Grade: 98%. CAS No. 7013-05-0. Molecular formula: C4H9NO3. Mole weight: 119.12. | |
| Gaboxadol | Gaboxadol is a GABA agonist. It was a non-opioid analgesic and a novel type of hypnotic. It was first synthesized in 1977 by the Danish chemist Povl Krogsgaard-Larsen. It is an experimental sleep aid drug developed by Lundbeck and Merck. It was used as an analgesic and anxiolytic, as well as a treatment for tardive dyskinesia, Huntington's disease, Alzheimer's disease, and spasticity. It was in clinic phase 3 trials, but now it was terminated. Uses: Gaboxadol was used as an analgesic and anxiolytic, as well as a treatment for tardive dyskinesia, huntington's disease, alzheimer's disease, and spasticity. Synonyms: OV-101; Lu-02-030; MK-0928; Lu-02030; MK0928; Lu02030; THIP; 4,5,6,7-Tetrahydroisoxazolo(5,4-c)pyridin-3(2H)-one; 4,5,6,7-Tetrahydro-[1,2]oxazolo[5,4-c]pyridin-6-ium-3-one. Grade: 98%. CAS No. 64603-91-4. Molecular formula: C6H8N2O2. Mole weight: 140.14. | |
| Gaboxadol hydrochloride | THIP hydrochloride is a GABAA receptor agonist and GABAA-ρ receptor antagonist. THIP exhibits antinociceptive, anticonvulsant and sedative effects. It is used as a hypnotic agent for the treatment of patients with insomnia. Uses: Hypnotic. Synonyms: THIP hydrochloride; Gaboxadol HCl. Grade: ≥ 98 % by HPLC. CAS No. 85118-33-8. Molecular formula: C6H8N2O2 ยท HCl. Mole weight: 176.60. | |
| Gadobutrol | Gadobutrol is a nonionic, paramagnetic contrast agent developed for tissue contrast enhancement in magnetic resonance imaging (MRI). It has a macrocyclic framework and is neutral. It is a water-soluble, highly hydrophilic compound with a partition coefficient between n-butanol and buffer at pH 7.6 of ~ 0.006. Uses: A gadolinium-based mri contrast agent (gbca). Synonyms: Gadograf; Gadovist; Protovist; ZK 135079; Gd-DO3A-butrol; Gallium 10-(1,3,4-trihydroxybutan-2-yl)-1,4,7,10-tetraazacyclododecane-1,4,7-tricarboxylate; AK325914; gallium. Grade: 98%. CAS No. 138071-82-6. Molecular formula: C18H31GdN4O9. Mole weight: 604.71. | |
| Gadobutrol Impurity 1 | Gadobutrol Impurity 1 is an impurity of Gadobutrol, which is a nonionic, paramagnetic contrast agent developed for tissue contrast enhancement in magnetic resonance imaging (MRI). Uses: Chelating agents. Synonyms: DOTA; Tetraxetan; 60239-18-1; 1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acid; Dota acid; 1,4,7,10-Dota; 1,4,7,10-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid; 2-[4,7,10-tris(carboxymethyl)-1,4,7,10-tetrazacyclododec-1-yl]acetic acid; CHEBI:61028; DOT-A; 2,2',2'',2'''-(1,4,7,10-tetraazacyclododecane-1,4,7,10-tetrayl)tetraacetic acid; MFCD00068657; NSC-681107; 1HTE449DGZ; MLS001333612; Tetraxetan (USAN); NSC681107; 2,2',2',2'''-(1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetryl)tetraacetic acid; SMR000857276; TETRAXETAN [USAN]; 2-[4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododecan-1-yl]acetic acid; UNII-1HTE449DGZ; tetraxetanum; gadoterate-meglumine; 1,4,7,10-Tetraazacyclododecane- 1,4,7,10-tetraacetic-acid; Gadobutrol impurity 1. Grade: > 95%. Molecular formula: C18H34N4O9. Mole weight: 450.49. | |
| Gadobutrol Impurity 10 | Gadobutrol Impurity 10 is an impurity of Gadobutrol, which is a nonionic, paramagnetic contrast agent developed for tissue contrast enhancement in magnetic resonance imaging (MRI). Grade: > 95%. Molecular formula: C16H27N4O8Gd. Mole weight: 560.67. | |
| Gadobutrol Impurity 11 | Gadobutrol Impurity 11 is an impurity of Gadobutrol, which is a nonionic, paramagnetic contrast agent developed for tissue contrast enhancement in magnetic resonance imaging (MRI). Grade: > 95%. Molecular formula: C14H26N4O6. Mole weight: 346.39. | |
| Gadobutrol Impurity 12 | Gadobutrol Impurity 12 is an impurity of Gadobutrol, which is a nonionic, paramagnetic contrast agent developed for tissue contrast enhancement in magnetic resonance imaging (MRI). Grade: > 95%. Molecular formula: C18H34N4O9. Mole weight: 450.49. | |
| Gadobutrol Impurity 13 | Gadobutrol Impurity 13 is an impurity of Gadobutrol, which is a nonionic, paramagnetic contrast agent developed for tissue contrast enhancement in magnetic resonance imaging (MRI). Grade: > 95%. Molecular formula: C20H40N4O10. Mole weight: 496.56. | |
| Gadobutrol Impurity 17 | Gadobutrol Impurity 17 is an impurity of Gadobutrol, which is a nonionic, paramagnetic contrast agent developed for tissue contrast enhancement in magnetic resonance imaging (MRI). Molecular formula: C16H36N4O6. Mole weight: 380.48. | |
| Gadobutrol Impurity 18 | Gadobutrol Impurity 18 is an impurity of Gadobutrol, which is a nonionic, paramagnetic contrast agent developed for tissue contrast enhancement in magnetic resonance imaging (MRI). Molecular formula: C16H36N4O6. Mole weight: 380.48. | |
| Gadobutrol Impurity 19 | Gadobutrol Impurity 19 is an impurity of Gadobutrol, which is a nonionic, paramagnetic contrast agent developed for tissue contrast enhancement in magnetic resonance imaging (MRI). Molecular formula: C15H32N4O3. Mole weight: 316.44. | |
| Gadobutrol Impurity 2 | Gadobutrol Impurity 2 is an impurity of Gadobutrol, which is a nonionic, paramagnetic contrast agent developed for tissue contrast enhancement in magnetic resonance imaging (MRI). Synonyms: Gadobutrol DiTOBO Ligand. Grade: > 95%. Molecular formula: C20H40N4O10. Mole weight: 496.55. | |
| Gadobutrol Impurity 20 | Gadobutrol Impurity 20 is an impurity of Gadobutrol, which is a nonionic, paramagnetic contrast agent developed for tissue contrast enhancement in magnetic resonance imaging (MRI). Molecular formula: C28H56N4O10. Mole weight: 608.76. | |
| Gadobutrol Impurity 21 | Gadobutrol Impurity 21 is an impurity of Gadobutrol, which is a nonionic, paramagnetic contrast agent developed for tissue contrast enhancement in magnetic resonance imaging (MRI). Molecular formula: C28H56N4O10. Mole weight: 608.76. | |
| Gadobutrol Impurity 22 | Gadobutrol Impurity 22 is an impurity of Gadobutrol, which is a nonionic, paramagnetic contrast agent developed for tissue contrast enhancement in magnetic resonance imaging (MRI). Molecular formula: C32H60N4O8. Mole weight: 628.84. | |
| Gadobutrol Impurity 23 | Gadobutrol Impurity 23 is an impurity of Gadobutrol, which is a nonionic, paramagnetic contrast agent developed for tissue contrast enhancement in magnetic resonance imaging (MRI). Molecular formula: C26H50N4O6. Mole weight: 514.70. | |
| Gadobutrol Impurity 2 4HCl (Mixture of Diastereomers) | Gadobutrol Impurity 2 4HCl (Mixture of Diastereomers) is an impurity of Gadobutrol, which is a nonionic, paramagnetic contrast agent developed for tissue contrast enhancement in magnetic resonance imaging (MRI). Molecular formula: C20H44Cl4N4O10. Mole weight: 642.39. | |
| Gadobutrol Impurity 26 | Gadobutrol Impurity 26 is an impurity of Gadobutrol, which is a nonionic, paramagnetic contrast agent developed for tissue contrast enhancement in magnetic resonance imaging (MRI). Molecular formula: C17H29GdN4O7. Mole weight: 558.68. | |
| Gadobutrol Impurity 27 | Gadobutrol Impurity 27 is an impurity of Gadobutrol, which is a nonionic, paramagnetic contrast agent developed for tissue contrast enhancement in magnetic resonance imaging (MRI). CAS No. 1822607-61-3. Molecular formula: C10H20N4. Mole weight: 196.29. | |
| Gadobutrol Impurity 28 | Gadobutrol Impurity 28 is an impurity of Gadobutrol, which is a nonionic, paramagnetic contrast agent developed for tissue contrast enhancement in magnetic resonance imaging (MRI). Molecular formula: C12H22N4. Mole weight: 222.33. | |
| Gadobutrol Impurity 29 | Gadobutrol Impurity 29 is an impurity of Gadobutrol, which is a nonionic, paramagnetic contrast agent developed for tissue contrast enhancement in magnetic resonance imaging (MRI). Synonyms: 2,2-dimethyl-4,7-dihydro-1,3-dioxepine. CAS No. 1003-83-4. Molecular formula: C7H12O2. Mole weight: 128.17. | |
| Gadobutrol Impurity 3 | Gadobutrol Impurity 3 is an impurity of Gadobutrol, which is a nonionic, paramagnetic contrast agent developed for tissue contrast enhancement in magnetic resonance imaging (MRI). Synonyms: Gd-DO3A. Grade: > 95%. CAS No. 112188-16-6. Molecular formula: C14H23GdN4O6. Mole weight: 500.60. | |
| Gadobutrol Impurity 30 | Gadobutrol Impurity 30 is an impurity of Gadobutrol, which is a nonionic, paramagnetic contrast agent developed for tissue contrast enhancement in magnetic resonance imaging (MRI). Molecular formula: C22H42N4O9. Mole weight: 506.59. | |
| Gadobutrol Impurity 31 | Gadobutrol Impurity 31 is an impurity of Gadobutrol, which is a nonionic, paramagnetic contrast agent developed for tissue contrast enhancement in magnetic resonance imaging (MRI). Molecular formula: C26H50N4O9. Mole weight: 562.69. | |
| Gadobutrol Impurity 4 | Gadobutrol Impurity 4 is an impurity of Gadobutrol, which is a nonionic, paramagnetic contrast agent developed for tissue contrast enhancement in magnetic resonance imaging (MRI). Synonyms: Gd-DOTA. Grade: > 95%. Molecular formula: C12H24N4O4. Mole weight: 288.35. | |
| Gadobutrol Impurity 5 | Gadobutrol Impurity 5 is an impurity of Gadobutrol, which is a nonionic, paramagnetic contrast agent developed for tissue contrast enhancement in magnetic resonance imaging (MRI). Grade: > 95%. Molecular formula: C36H44N4. Mole weight: 532.78. | |
| Gadobutrol Impurity 6 | Gadobutrol Impurity 6 is an impurity of Gadobutrol, which is a nonionic, paramagnetic contrast agent developed for tissue contrast enhancement in magnetic resonance imaging (MRI). Grade: > 95%. Molecular formula: C20H38N4O10ClGd. Mole weight: 687.25. | |
| Gadobutrol Impurity 7 | Gadobutrol Impurity 7 is an impurity of Gadobutrol, which is a nonionic, paramagnetic contrast agent developed for tissue contrast enhancement in magnetic resonance imaging (MRI). Grade: > 95%. Molecular formula: C20H40N4O10. Mole weight: 496.56. | |
| Gadobutrol Impurity 8 | Gadobutrol Impurity 8 is an impurity of Gadobutrol, which is a nonionic, paramagnetic contrast agent developed for tissue contrast enhancement in magnetic resonance imaging (MRI). Grade: > 95%. Molecular formula: C20H38N4O10ClGd. Mole weight: 687.25. | |
| Gadobutrol Sodium Salt | Gadobutrol Sodium Salt is an impurity of Gadobutrol, which is a nonionic, paramagnetic contrast agent developed for tissue contrast enhancement in magnetic resonance imaging (MRI). Synonyms: Calcobutrol Sodium Salt. Molecular formula: C18H31N4O9Na3. Mole weight: 516.43. | |
| Gadodiamide | Gadodiamide(Omniscan) is a gadolinium-based MRI contrast agent, used in MR imaging procedures to assist in the visualization of blood vessels. Synonyms: Gadodiamide, Gd-Dtpa-Bma; Gadodiamide; DV 7572; DV-7572; DV7572; Omniscan; S 041; S-041; S041. Grade: >98%. CAS No. 131410-48-5. Molecular formula: C16H26GdN5O8. Mole weight: 573.66. | |
| Gadodiamide hydrate | Gadodiamide, a nonionic Gd3+ chelate, is frequently injected i.v. into magnetic resonance imaging (MRI) to enhance contrast. Grade: >98%. CAS No. 122795-43-1. Molecular formula: C16H28GdN5O9C16H28GdN5O9.xH2O. Mole weight: 591.67. | |
| Gadolinium chloride | Gadolinium chloride is a calcium-sensing receptor (CaSR) agonist that induces NLRP3 inflammasome activation in bone marrow-derived macrophages. Gadolinium chloride blocks stretch-activated calcium channels, and disrupts the increase in intracellular calcium ion concentration in hypotonic-stimulated pulmonary artery smooth muscle cells. Gadolinium chloride also exhibits an inhibitory effect on TRPML channel currents and other TRP channels. Synonyms: Gadolinium trichloride; trichlorogadolinium. CAS No. 10138-52-0. Molecular formula: GdCl3. Mole weight: 263.61. | |
| Gadoquatrane | Gadoquatrane is a diagnostic imaging agent. Synonyms: rac-[{μ4-2,2',2'',2''',2'''',2'''''-[{(2R,16Ξ)-3,6,12,15-tetraoxo-1κO3:2κO15-9,9-bis[(2-{(2Ξ)-2-[4,7,10-tris(carboxy-3κ3O4,O7,O10:4κ3O4',O7',O10'-methyl)-1,4,7,10-tetraazacyclododecan-1-yl-3κ4N1,N4,N7,N10:4κ4N1',N4',N7',N10']-propanamido-3κO:4κO'}acetamido)methyl]-4,7,11,14-tetraazaheptadecane-2,16-diyl}bis(1,4,7,10-tetraazacyclododecane-10,1,4,7-tetrayl-1κ4N1,N4,N7,N10:2κ4N1',N4',N7',N10')]hexaacetato-1κ3O1,O4,O7:-2κ3O1',O4',O7'}(12-)]tetragadolinium. CAS No. 2048221-65-2. Molecular formula: C81H128Gd4N24O32. Mole weight: 2579.05. | |
| Gadoteridol | Gadoteridol is a gadolinium-based MRI contrast agent which is commonly used in central nervous system imaging. It is sold under the brand name ProHance. Uses: Gadoteridol is a mri contrast agent that commonly used in central nervous system imaging. Synonyms: [10-(2-Hydroxypropyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triacetato(3-)-N1,N4,N7,N10,O1,O4,O7,O10]gadolinium; 1,4,7,10-Tetraazacyclododecane Gadolinium deriv.; 10-(2-Hydroxypropyl)-1,4,7,10-Tetraazacyclododecane-1,4,7-triacetic Acid Gadolinium Complex; (10-(2-Hydroxypropyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triacetato)gadolinium; GD-HP-DO 3A; Gadolinium-HP-DO 3A; Gadoteridol; ProHance; SQ 32692. Grade: 95%. CAS No. 120066-54-8. Molecular formula: C17H29GdN4O7. Mole weight: 558.68. | |
| Gadoteridol Impurity 1 | Gadoteridol Impurity 1. Grade: > 95%. Molecular formula: C16H27N4O7Cl. Mole weight: 422.87. | |
| Gadoteridol Impurity 15 4HCl | Gadoteridol Impurity 15 4HCl (DO2A 4HCl) is an impurity of Gadoteridol. Gadoterido is a gadolinium-based MRI contrast agent. It is sold under the brand name ProHance. Synonyms: 1,4,7,10-Tetraazacyclododecane-1,7-Diacetic Acid hydrochloride (1:4); 2,2'-(1,4,7,10-Tetraazacyclododecane-1,7-Diyl)Diacetic Acid hydrochloride (1:4); NSC681105 hydrochloride; DO2A 4HCl. Molecular formula: C12H28Cl4N4O4. Mole weight: 434.19. | |
| Ga(III) protoporphyrin IX | Ga(III)protoporphyrin-IX acts as a potent antibacterial against gram-negative, gram-positive, and acid-fast bacteria. CAS No. 222556-71-0. Molecular formula: C34H31GaN4O4. Mole weight: 629.36. | |
| GAK inhibitor 49 | A potent, ATP-competitive and highly selective cyclin G associated kinase (GAK) inhibitor, and also a RIPK2 inhibitor. Synonyms: 6,7-dimethoxy-N-(3,4,5-trimethoxyphenyl)quinolin-4-amine. Grade: 98%. CAS No. 319492-82-5. Molecular formula: C20H22N2O5. Mole weight: 370.4. | |
| GAL-021 | GAL-021 a novel intravenous BKCa-channel blocker potentially for the treatment of respiratory depression. Synonyms: 2-N-methoxy-2-N-methyl-4-N,6-N-dipropyl-1,3,5-triazine-2,4,6-triamine; GAL-021; GAL021. CAS No. 1380341-99-0. Molecular formula: C11H22N6O. Mole weight: 254.33. | |
| Gal[2346Ac]b(1-3)GalN3[46Bzd]-b-MP | Gal[2346Ac]b(1-3)GalN3[46Bzd]-b-MP is a valuable tool used to investigate carbohydrate-protein interactions. It is particularly useful for studying diseases involving aberrant glycosylation patterns, such as cancer and certain genetic disorders. Synonyms: 4-Methoxyphenyl 3-O-(2,3,4,6-Tetra-O-acetyl-b-D-galactopyranosyl)-2-azido-4,6-O-benzylidene-2-deoxy-b-D-galactopyranoside. Molecular formula: C34H39N3O15. Mole weight: 729.68. | |
| Gal[2346Ac]b(1-3)GlcN3[46Bzd]-b-MP | Gal[2346Ac]b(1-3)GlcN3[46Bzd]-b-MP is a modified peptide of biomedical importance. Its unique design facilitates targeted interactions with specific receptors or drug compounds responsible for the manifestation of these ailments. Synonyms: 4-Methoxyphenyl 3-O-(2,3,4,6-Tetra-O-acetyl-b-D-galactopyranosyl)-2-azido-4,6-O-benzylidene-2-deoxy-b-D-glucopyranoside. Molecular formula: C34H39N3O15. Mole weight: 729.68. | |
| Gal[2346Ac]b(1-3)GlcNPhth[46Bzd]-b-MP | Gal[2346Ac]b(1-3)GlcNPhth[46Bzd]-b-MP is a biomedical compound, used for comprehending the intricacies of interactions and repercussions caused by Gal, GlcNPhth and MP compounds on diverse pharmaceuticals and maladies. Synonyms: 4-Methoxyphenyl 3-O-(2,3,4,6-Tetra-O-acetyl-b-D-galactopyranosyl)-4,6-O-benzylidene-2-deoxy-2-phthalimido-b-D-glucopyranoside. Molecular formula: C42H43NO17. Mole weight: 833.79. | |
| Gal[2346Ac]β(1-4)Glc[236Ac]-β-MP | Gal[2346Ac]β(1-4)Glc[236Ac]-β-MP. Synonyms: β-D-Glucopyranoside, 4-methoxyphenyl 4-O-(2,3,4,6-tetra-O-acetyl-β-D-galactopyranosyl)-, 2,3,6-triacetate; β-D-Glucopyranoside, 4-methoxyphenyl 4-O-(2,3,4,6-tetra-O-acetyl-β-D-galactopyranosyl)-, triacetate; 4-Methoxyphenyl 4-O-β-D-galactopyranosyl-β-D-glucopyranoside heptaacetate; 4-Methoxyphenyl 4-O-(2,3,4,6-tetra-O-acetyl-β-D-galactopyranosyl)-β-D-glucopyranoside 2,3,6-triacetate; 4-Methoxyphenyl 4-O-(2,3,4,6-Tetra-O-acetyl-β-D-galactopyranosyl)-2,3,6-tri-O-acetyl-β-D-glucopyranoside. Grade: ≥98%. CAS No. 160227-12-3. Molecular formula: C33H42O19. Mole weight: 742.68. | |
| Gal[3All,246Bn]b(1-3)GlcNPhth[6Bn]-b-MP | Gal[3All,246Bn]b(1-3)GlcNPhth[6Bn]-b-MP is a widely utilized compound in the biomedical industry, used to study a plethora of ailments such as cancer, autoimmune disorders and inflammatory conditions. Molecular formula: C58H59NO13. Mole weight: 978.09. | |
| Gala1-2Gal-BSA | Gala1-2Gal-BSA. | |
Our database is helping our users find suppliers everyday.
